School of Nursing, College of Nursing, Taipei Medical University, Taipei, Taiwan, and with the School of Nursing, Faculty of Health Sciences, Alma Ata University, Yogyakarta, Indonesia.
Department of Nutrition, Faculty of Health Sciences, Alma Ata University, Yogyakarta, Indonesia.
Respir Care. 2019 Sep;64(9):1146-1156. doi: 10.4187/respcare.06959.
Studies on the effect of transitional care on hospital readmissions have reported inconsistent findings, and the effect on mortality has not been reviewed systematically. This systematic review and meta-analysis of randomized controlled trials aims to examine the effect of transitional care interventions on COPD-related readmissions, all-cause hospital readmissions, and all-cause mortality rates in subjects with COPD.
Electronic databases (CINAHL, Embase, Scopus, MEDLINE, Cochrane, PubMed, Web of Science, Airity, BMJ Respiratory Research Journal, and National Digital Library of Theses and Dissertations) were searched from inception to April 26, 2017. Online searches were conducted using key words and MeSH terms for COPD and transitional care. Entry terms for searching included chronic obstructive pulmonary disease, COPD, COPD transitional care or care transition, continuity of patient care, patient discharge, and patient transfer. The quality of the included trials was assessed using the Cochrane Collaboration tool.
13 randomized controlled trials met the inclusion criteria. Transitional care significantly reduced the risk of COPD-related readmissions (odds ratio = 0.599, 95% CI 0.421-0.852) and all-cause hospital readmissions (odds ratio = 0.720, 95% CI 0.531-0.978), but not that of all-cause mortality (odds ratio = 0.863, 95% CI 0.576-1.294) in subjects with COPD. The effects of transitional care on hospital readmissions were moderated by the duration of interventions, type of care providers, and use of telephone follow-up as an element of the intervention.
There was a significant effect of transitional care on both COPD-related and all-cause hospital readmissions in subjects with COPD. Duration of interventions, type of care providers, and use of telephone follow-up appeared to moderate the beneficial effects of transitional care.
关于过渡护理对医院再入院的影响的研究结果不一致,且其对死亡率的影响尚未进行系统评价。本项系统评价和随机对照试验的荟萃分析旨在考察过渡护理干预对慢性阻塞性肺疾病(COPD)相关再入院、全因住院再入院和全因死亡率的影响。
从建库到 2017 年 4 月 26 日,电子数据库(CINAHL、Embase、Scopus、MEDLINE、Cochrane、PubMed、Web of Science、Airity、BMJ 呼吸道研究杂志和国家学位论文数字图书馆)进行了检索。在线搜索使用了 COPD 和过渡护理的关键词和 MeSH 术语。搜索的输入词包括慢性阻塞性肺疾病、COPD、COPD 过渡护理或护理转换、患者护理的连续性、患者出院和患者转移。使用 Cochrane 协作工具评估纳入试验的质量。
13 项随机对照试验符合纳入标准。过渡护理显著降低了 COPD 相关再入院(比值比=0.599,95%置信区间 0.421-0.852)和全因住院再入院(比值比=0.720,95%置信区间 0.531-0.978)的风险,但不能降低全因死亡率(比值比=0.863,95%置信区间 0.576-1.294)。过渡护理对住院再入院的影响受到干预持续时间、护理提供者类型以及将电话随访作为干预要素的影响。
过渡护理对 COPD 患者的 COPD 相关和全因住院再入院有显著影响。干预持续时间、护理提供者类型以及使用电话随访似乎调节了过渡护理的有益效果。